{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:56:54Z","timestamp":1767923814752,"version":"3.49.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T00:00:00Z","timestamp":1444176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T00:00:00Z","timestamp":1444176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s11908-015-0506-5","type":"journal-article","created":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T08:55:17Z","timestamp":1444208117000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["The Reemergence of Measles"],"prefix":"10.1007","volume":"17","author":[{"given":"C. L.","family":"Abad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Safdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,7]]},"reference":[{"key":"506_CR1","first-page":"373","volume":"64","author":"NS Clemmons","year":"2015","unstructured":"Clemmons NS, Gastanaduy PA, Fiebelkorn AP, Redd SB, Wallace GS. Measles\u2014United States, January 4\u2013April 2, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:373\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"506_CR2","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/S0140-6736(12)60522-4","volume":"379","author":"E Simons","year":"2012","unstructured":"Simons E, Ferrari M, Fricks J, et al. Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet. 2012;379:2173\u20138.","journal-title":"Lancet"},{"key":"506_CR3","unstructured":"World Health Organization. Global measles and rubella strategic plan: 2012\u20132020. Geneva, 2012."},{"issue":"Suppl 1","key":"506_CR4","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1086\/377696","volume":"189","author":"SL Katz","year":"2004","unstructured":"Katz SL, Hinman AR. Summary and conclusions: measles elimination meeting, 16\u201317 March 2000. J Infect Dis. 2004;189 Suppl 1:S43\u20137.","journal-title":"J Infect Dis"},{"key":"506_CR5","unstructured":"Plotkin SA OW, Offit PA, eds. Vaccines. 6th ed. Philadelphia: Elsevier, 2012; 2012."},{"key":"506_CR6","unstructured":"Centers for Disease Control and Prevention. Measles (rubeola): for healthcare professionals. 2014. http:\/\/www.cdc.gov\/measles\/hcp\/index.html."},{"key":"506_CR7","unstructured":"World Health Organization (WHO) Regional Office for Europe. Guidelines for measles and rubella outbreak investigation and response in the WHO European Region. Copenhagen: WHO. 2013. Available from: http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0003\/217164\/OutbreakGuidelines-updated.pdf."},{"key":"506_CR8","unstructured":"European Centre for Disease Prevention and Control (ECDC). Annual epidemiological report: Reporting on 2011 surveillance data and 2012 epidemic intelligence data. Stockholm: ECDC. 2013. Available from: http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/annual-epidemiological-report-2013.pdf."},{"key":"506_CR9","doi-asserted-by":"crossref","unstructured":"Pegorie M, Shankar K, Welfare WS, et al. Measles outbreak in Greater Manchester, England, October 2012 to September 2013: epidemiology and control. Euro Surveill. 2014;19.","DOI":"10.2807\/1560-7917.ES2014.19.49.20982"},{"key":"506_CR10","first-page":"1331","volume-title":"Nelson textbook of pediatrics","author":"WH Mason","year":"2007","unstructured":"Mason WH. Measles. In: Kliegman RMBR, Jenson HB, Stanton BF, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia: Saunders; 2007. p. 1331\u20137.","edition":"18"},{"key":"506_CR11","first-page":"173","volume-title":"Epidemiology and prevention of vaccine-preventable diseases","author":"United States Centers for Disease Control and Prevention","year":"2011","unstructured":"United States Centers for Disease Control and Prevention. Measles. In: Atkinson W, editor. Epidemiology and prevention of vaccine-preventable diseases. 12th ed. Washington, DC: Public Health Foundation; 2011. p. 173\u201392.","edition":"12"},{"key":"506_CR12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/B978-1-4160-3611-1.50022-2","volume-title":"Vaccines","author":"PM Strebel","year":"2008","unstructured":"Strebel PM. Measles vaccine. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. Philadelphia: Saunders-Elsevier; 2008. p. 353\u201398."},{"key":"506_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijid.2013.10.010","volume":"20","author":"Y Hirai","year":"2014","unstructured":"Hirai Y, Asahata S, Ainoda Y, Fujita T, Kawashima M, Totsuka K. Truncal rash in adult measles. Int J Infect Dis. 2014;20:80\u20131.","journal-title":"Int J Infect Dis"},{"key":"506_CR14","unstructured":"WHO Expanded Programme on Immunization. Manual for the laboratory diagnosis of measles and rubella virus infection, 2nd ed. Geneva, World Health Organization, 2006 (http:\/\/www.who.int\/immunization_monitoring\/LabManualFinal.pdf)."},{"key":"506_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/path.1700760112","volume":"76","author":"GB Roberts","year":"1958","unstructured":"Roberts GB, Bain AD. The pathology of measles. J Pathol Bacteriol. 1958;76:111\u20138.","journal-title":"J Pathol Bacteriol"},{"key":"506_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/321009","volume":"184","author":"SF Atabani","year":"2001","unstructured":"Atabani SF, Byrnes AA, Jaye A, et al. Natural measles causes prolonged suppression of interleukin-12 production. J Infect Dis. 2001;184:1\u20139.","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"506_CR17","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1093\/infdis\/170.Supplement_1.S24","volume":"170","author":"DE Griffin","year":"1994","unstructured":"Griffin DE, Ward BJ, Esolen LM. Pathogenesis of measles virus infection: an hypothesis for altered immune responses. J Infect Dis. 1994;170 Suppl 1:S24\u201331.","journal-title":"J Infect Dis"},{"key":"506_CR18","first-page":"139","volume":"15","author":"S Schneider-Schaulies","year":"1999","unstructured":"Schneider-Schaulies S, ter Meulen V. Pathogenic aspects of measles virus infections. Arch Virol Suppl. 1999;15:139\u201358.","journal-title":"Arch Virol Suppl"},{"key":"506_CR19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/B978-1-4160-3611-1.50022-2","volume-title":"Vaccines","author":"PM Strebel","year":"2008","unstructured":"Strebel PM. Measles vaccine. In: Plotkin SAOW, Offit PA, editors. Vaccines. 5th ed. Philadelphia: Saunders-Elsevier; 2008. p. 353\u201398.","edition":"5"},{"issue":"Suppl 1","key":"506_CR20","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1086\/377712","volume":"189","author":"RT Perry","year":"2004","unstructured":"Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis. 2004;189 Suppl 1:S4\u201316.","journal-title":"J Infect Dis"},{"key":"506_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0163-4453(89)92164-6","volume":"19","author":"BA Crosse","year":"1989","unstructured":"Crosse BA. Subcutaneous and mediastinal emphysema complication of measles. J Infect. 1989;19:190.","journal-title":"J Infect"},{"issue":"Suppl 6","key":"506_CR22","doi-asserted-by":"publisher","first-page":"S555","DOI":"10.1093\/clinids\/13.Supplement_6.S555","volume":"13","author":"LE Markowitz","year":"1991","unstructured":"Markowitz LE, Nieburg P. The burden of acute respiratory infection due to measles in developing countries and the potential impact of measles vaccine. Rev Infect Dis. 1991;13 Suppl 6:S555\u201361.","journal-title":"Rev Infect Dis"},{"key":"506_CR23","first-page":"169","volume":"96","author":"A Sharma","year":"1993","unstructured":"Sharma A. A rare complication of measles: subcutaneous and mediastinal emphysema. J Trop Med Hyg. 1993;96:169\u201371.","journal-title":"J Trop Med Hyg"},{"key":"506_CR24","first-page":"227","volume-title":"Viral infections of the nervous system","author":"RT Johnson","year":"1998","unstructured":"Johnson RT. Inflammatory and demyelinating diseases. In: Johnson RT, editor. Viral infections of the nervous system. 2nd ed. Philadelphia: Lippincott-Raven; 1998. p. 227\u201364.","edition":"2"},{"key":"506_CR25","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/00004836-199412000-00006","volume":"19","author":"N Cohen","year":"1994","unstructured":"Cohen N, Golik A, Blatt A, et al. Pancreatic enzyme elevation in measles. J Clin Gastroenterol. 1994;19:292\u20135.","journal-title":"J Clin Gastroenterol"},{"key":"506_CR26","first-page":"901","volume":"59","author":"FT Koster","year":"1981","unstructured":"Koster FT, Curlin GC, Aziz KM, Haque A. Synergistic impact of measles and diarrhoea on nutrition and mortality in Bangladesh. Bull World Health Organ. 1981;59:901\u20138.","journal-title":"Bull World Health Organ"},{"key":"506_CR27","first-page":"1112","volume":"67","author":"DC Morley","year":"1974","unstructured":"Morley DC. Measles in the developing world. Proc R Soc Med. 1974;67:1112\u20135.","journal-title":"Proc R Soc Med"},{"key":"506_CR28","first-page":"2054","volume-title":"Textbook of pediatric infectious diseases","author":"JD Cherry","year":"1988","unstructured":"Cherry JD. Measles. In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases. 4th ed. Philadelphia: WB Saunders; 1988. p. 2054\u201374.","edition":"4"},{"key":"506_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF00158318","volume":"14","author":"A Sommer","year":"1990","unstructured":"Sommer A. Xerophthalmia, keratomalacia and nutritional blindness. Int Ophthalmol. 1990;14:195\u20139.","journal-title":"Int Ophthalmol"},{"key":"506_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0022-3476(56)80116-9","volume":"48","author":"JB Hudson","year":"1956","unstructured":"Hudson JB, Weinstein L, Chang TW. Thrombocytopenic purpura in measles. J Pediatr. 1956;48:48\u201356.","journal-title":"J Pediatr"},{"key":"506_CR31","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/archinte.1983.00350040064008","volume":"143","author":"D Gavish","year":"1983","unstructured":"Gavish D, Kleinman Y, Morag A, Chajek-Shaul T. Hepatitis and jaundice associated with measles in young adults. An analysis of 65 cases. Arch Intern Med. 1983;143:674\u20137.","journal-title":"Arch Intern Med"},{"key":"506_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0197-0070(88)90072-1","volume":"9","author":"L Leibovici","year":"1988","unstructured":"Leibovici L, Sharir T, Kalter-Leibovici O, Alpert G, Epstein LM. An outbreak of measles among young adults. Clinical and laboratory features in 461 patients. J Adolesc Health Care. 1988;9:203\u20137.","journal-title":"J Adolesc Health Care"},{"key":"506_CR33","first-page":"93","volume":"46","author":"LJ Casanova-Cardiel","year":"1994","unstructured":"Casanova-Cardiel LJ, Hermida-Escobedo C. Measles in the young adult. Clinical features of 201 cases. Rev Investig Clin. 1994;46:93\u20138.","journal-title":"Rev Investig Clin"},{"key":"506_CR34","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S0140-6736(98)10101-0","volume":"354","author":"NS Wairagkar","year":"1999","unstructured":"Wairagkar NS, Gandhi BV, Katrak SM, et al. Acute renal failure with neurological involvement in adults associated with measles virus isolation. Lancet. 1999;354:992\u20135.","journal-title":"Lancet"},{"key":"506_CR35","volume-title":"Principles and practice of transplant infectious diseases","author":"J Waggoner","year":"2013","unstructured":"Waggoner J, Deresinski S. Rare and emerging viral infection in the transplant population. In: Safdar A, editor. Principles and practice of transplant infectious diseases. Berlin: Springer Medizin; 2013."},{"key":"506_CR36","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/j.1600-6143.2006.01330.x","volume":"6","author":"A Turner","year":"2006","unstructured":"Turner A, Jeyaratnam D, Haworth F, et al. Measles-associated encephalopathy in children with renal transplants. Am J Transplant. 2006;6:1459\u201365.","journal-title":"Am J Transplant"},{"key":"506_CR37","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/jama.1992.03480090085032","volume":"267","author":"LJ Kaplan","year":"1992","unstructured":"Kaplan LJ, Daum RS, Smaron M, McCarthy CA. Severe measles in immunocompromised patients. JAMA. 1992;267:1237\u201341.","journal-title":"JAMA"},{"key":"506_CR38","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1001\/jama.1989.03420170056030","volume":"261","author":"K Krasinski","year":"1989","unstructured":"Krasinski K, Borkowsky W. Measles and measles immunity in children infected with human immunodeficiency virus. JAMA. 1989;261:2512\u20136.","journal-title":"JAMA"},{"key":"506_CR39","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/00006454-199107000-00014","volume":"10","author":"S Nadel","year":"1991","unstructured":"Nadel S, McGann K, Hodinka RL, Rutstein R, Chatten J. Measles giant cell pneumonia in a child with human immunodeficiency virus infection. Pediatr Infect Dis J. 1991;10:542\u20134.","journal-title":"Pediatr Infect Dis J"},{"key":"506_CR40","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1097\/00006454-199211120-00004","volume":"11","author":"P Palumbo","year":"1992","unstructured":"Palumbo P, Hoyt L, Demasio K, Oleske J, Connor E. Population-based study of measles and measles immunization in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1992;11:1008\u201314.","journal-title":"Pediatr Infect Dis J"},{"key":"506_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0022-3476(94)70125-3","volume":"125","author":"BJ Rudy","year":"1994","unstructured":"Rudy BJ, Rutstein RM, Pinto-Martin J. Responses to measles immunization in children infected with human immunodeficiency virus. J Pediatr. 1994;125:72\u20134.","journal-title":"J Pediatr"},{"key":"506_CR42","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/clinids\/19.3.454","volume":"19","author":"AL Forni","year":"1994","unstructured":"Forni AL, Schluger NW, Roberts RB. Severe measles pneumonitis in adults: evaluation of clinical characteristics and therapy with intravenous ribavirin. Clin Infect Dis. 1994;19:454\u201362.","journal-title":"Clin Infect Dis"},{"key":"506_CR43","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0002-9343(90)90162-7","volume":"88","author":"LA Ross","year":"1990","unstructured":"Ross LA, Kim KS, Mason Jr WH, Gomperts E. Successful treatment of disseminated measles in a patient with acquired immunodeficiency syndrome: consideration of antiviral and passive immunotherapy. Am J Med. 1990;88:313\u20134.","journal-title":"Am J Med"},{"key":"506_CR44","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1097\/00007611-199312000-00023","volume":"86","author":"SW Stogner","year":"1993","unstructured":"Stogner SW, King JW, Black-Payne C, Bocchini J. Ribavirin and intravenous immune globulin therapy for measles pneumonia in HIV infection. South Med J. 1993;86:1415\u20138.","journal-title":"South Med J"},{"key":"506_CR45","unstructured":"WHO guidelines for epidemic preparedness and response to measles outbreaks. 1999. Accessed 1 June 2015, at http:\/\/www.who.int\/csr\/resources\/publications\/measles\/WHO_CDS_CSR_ISR_99_1\/en\/."},{"key":"506_CR46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0140-6736(10)62352-5","volume":"379","author":"WJ Moss","year":"2012","unstructured":"Moss WJ, Griffin DE. Measles. Lancet. 2012;379:153\u201364.","journal-title":"Lancet"},{"key":"506_CR47","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1542\/peds.76.4.524","volume":"76","author":"AB Bloch","year":"1985","unstructured":"Bloch AB, Orenstein WA, Stetler HC, et al. Health impact of measles vaccination in the United States. Pediatrics. 1985;76:524\u201332.","journal-title":"Pediatrics"},{"key":"506_CR48","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1001\/jama.1979.03300110029022","volume":"242","author":"AR Hinman","year":"1979","unstructured":"Hinman AR, Brandling-Bennett AD, Nieburg PI. The opportunity and obligation to eliminate measles from the United States. JAMA. 1979;242:1157\u201362.","journal-title":"JAMA"},{"issue":"Suppl 1","key":"506_CR49","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1086\/377694","volume":"189","author":"AR Hinman","year":"2004","unstructured":"Hinman AR, Orenstein WA, Papania MJ. Evolution of measles elimination strategies in the United States. J Infect Dis. 2004;189 Suppl 1:S17\u201322.","journal-title":"J Infect Dis"},{"key":"506_CR50","first-page":"1","volume":"62","author":"HQ McLean","year":"2013","unstructured":"McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62:1\u201334.","journal-title":"MMWR Recomm Rep"},{"key":"506_CR51","unstructured":"Measles prevention. MMWR Morb Mortal Wkly Rep 1989;38 Suppl 9:1\u201318."},{"key":"506_CR52","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/cid\/cis439","volume":"55","author":"G De Serres","year":"2012","unstructured":"De Serres G, Boulianne N, Defay F, et al. Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12\u201314 months versus 15 months of age. Clin Infect Dis. 2012;55:394\u2013402.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"506_CR53","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.1093\/infdis\/jir102","volume":"204","author":"A Uzicanin","year":"2011","unstructured":"Uzicanin A, Zimmerman L. Field effectiveness of live attenuated measles-containing vaccines: a review of published literature. J Infect Dis. 2011;204 Suppl 1:S133\u201348.","journal-title":"J Infect Dis"},{"key":"506_CR54","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1017\/S0950268800058441","volume":"115","author":"G De Serres","year":"1995","unstructured":"De Serres G, Boulianne N, Meyer F, Ward BJ. Measles vaccine efficacy during an outbreak in a highly vaccinated population: incremental increase in protection with age at vaccination up to 18 months. Epidemiol Infect. 1995;115:315\u201323.","journal-title":"Epidemiol Infect"},{"key":"506_CR55","first-page":"1407","volume":"155","author":"PA Sutcliffe","year":"1996","unstructured":"Sutcliffe PA, Rea E. Outbreak of measles in a highly vaccinated secondary school population. CMAJ. 1996;155:1407\u201313.","journal-title":"CMAJ"},{"key":"506_CR56","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/00006454-199907000-00010","volume":"18","author":"CR Vitek","year":"1999","unstructured":"Vitek CR, Aduddell M, Brinton MJ, Hoffman RE, Redd SC. Increased protections during a measles outbreak of children previously vaccinated with a second dose of measles-mumps-rubella vaccine. Pediatr Infect Dis J. 1999;18:620\u20133.","journal-title":"Pediatr Infect Dis J"},{"key":"506_CR57","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1542\/peds.2004-2718","volume":"116","author":"LF Yeung","year":"2005","unstructured":"Yeung LF, Lurie P, Dayan G, et al. A limited measles outbreak in a highly vaccinated US boarding school. Pediatrics. 2005;116:1287\u201391.","journal-title":"Pediatrics"},{"key":"506_CR58","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/00006454-199002000-00008","volume":"9","author":"LE Markowitz","year":"1990","unstructured":"Markowitz LE, Preblud SR, Fine PE, Orenstein WA. Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J. 1990;9:101\u201310.","journal-title":"Pediatr Infect Dis J"},{"key":"506_CR59","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1086\/528993","volume":"197","author":"I Davidkin","year":"2008","unstructured":"Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis. 2008;197:950\u20136.","journal-title":"J Infect Dis"},{"key":"506_CR60","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1001\/archpedi.161.3.294","volume":"161","author":"CW LeBaron","year":"2007","unstructured":"LeBaron CW, Beeler J, Sullivan BJ, et al. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment. Arch Pediatr Adolesc Med. 2007;161:294\u2013301.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"506_CR61","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/infdis\/166.1.205","volume":"166","author":"LE Markowitz","year":"1992","unstructured":"Markowitz LE, Albrecht P, Orenstein WA, Lett SM, Pugliese TJ, Farrell D. Persistence of measles antibody after revaccination. J Infect Dis. 1992;166:205\u20138.","journal-title":"J Infect Dis"},{"key":"506_CR62","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/infdis\/172.6.1591","volume":"172","author":"BJ Ward","year":"1995","unstructured":"Ward BJ, Boulianne N, Ratnam S, Guiot MC, Couillard M, De Serres G. Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination. J Infect Dis. 1995;172:1591\u20135.","journal-title":"J Infect Dis"},{"key":"506_CR63","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1590\/S0036-36341997000100009","volume":"39","author":"J Fernandez-de Castro","year":"1997","unstructured":"Fernandez-de Castro J, Kumate-Rodriguez J, Sepulveda J, Ramirez-Isunza JM, Valdespino-Gomez JL. Measles vaccination by the aerosol method in Mexico. Salud Publica Mex. 1997;39:53\u201360.","journal-title":"Salud Publica Mex"},{"key":"506_CR64","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1056\/NEJMoa1407417","volume":"372","author":"N Low","year":"2015","unstructured":"Low N, Bavdekar A, Jeyaseelan L, et al. A randomized, controlled trial of an aerosolized vaccine against measles. N Engl J Med. 2015;372:1519\u201329.","journal-title":"N Engl J Med"},{"key":"506_CR65","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1590\/S1020-49892002001000004","volume":"12","author":"BA Dos Santos","year":"2002","unstructured":"Dos Santos BA, Ranieri TS, Bercini M, et al. An evaluation of the adverse reaction potential of three measles-mumps-rubella combination vaccines. Rev Panam Salud Publica. 2002;12:240\u20136.","journal-title":"Rev Panam Salud Publica"},{"key":"506_CR66","first-page":"511","volume":"30","author":"S Gatchalian","year":"1999","unstructured":"Gatchalian S, Cordero-Yap L, Lu-Fong M, et al. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12\u201324 months of age. Southeast Asian J Trop Med Public Health. 1999;30:511\u20137.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"506_CR67","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3109\/inf.1973.5.issue-4.01","volume":"5","author":"L Grillner","year":"1973","unstructured":"Grillner L, Hedstrom CE, Bergstrom H, Forssman L, Rigner A, Lycke E. Vaccination against rubella of newly delivered women. Scand J Infect Dis. 1973;5:237\u201341.","journal-title":"Scand J Infect Dis"},{"key":"506_CR68","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(86)91044-5","volume":"1","author":"H Peltola","year":"1986","unstructured":"Peltola H, Heinonen OP. Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet. 1986;1:939\u201342.","journal-title":"Lancet"},{"key":"506_CR69","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3181\/00379727-165-40979","volume":"165","author":"RE Weibel","year":"1980","unstructured":"Weibel RE, Carlson Jr AJ, Villarejos VM, Buynak EB, McLean AA, Hilleman MR. Clinical and laboratory studies of combined live measles, mumps, and rubella vaccines using the RA 27\/3 rubella virus. Proc Soc Exp Biol Med. 1980;165:323\u20136.","journal-title":"Proc Soc Exp Biol Med"},{"key":"506_CR70","volume":"2","author":"V Demicheli","year":"2012","unstructured":"Demicheli V, Rivetti A, Debalini MG, Di Pietrantonj C. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev. 2012;2, CD004407.","journal-title":"Cochrane Database Syst Rev"},{"key":"506_CR71","unstructured":"Evidence concerning rubella vaccines and arthritis, radiculoneuritis, and thrombocytopenic purpura. Adverse effects of pertussis and rubella vaccines: a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines. In: Howson CP, Howe CJ, HVF, editors. Institute of Medicine. Washington, DC: National Academy Press; 1991:187\u2013205."},{"key":"506_CR72","unstructured":"Measles and mumps vaccines. Adverse events associated with childhood vaccines evidence bearing on causality. In: Stratton KR, Howe CJ, Johnston RBJ, editors. Institute of Medicine. Washington, DC: National Academy Press; 1994:118\u201386."},{"key":"506_CR73","unstructured":"Immunization safety review: measles-mumps-rubella vaccine and autism. In: Stratton K, Gable A, Shetty P, M M, editors. Institute of Medicine. Washington, DC: National Academy Press; 2001."},{"key":"506_CR74","unstructured":"Immunization safety review: vaccines and autism Institute of Medicine. Washington, DC: National Academy Press; 2004."},{"key":"506_CR75","unstructured":"Measles, mumps, and rubella vaccine. Adverse effects of vaccines: evidence and causality Institute of Medicine Washington, DC; The National Academies Press; 2012."},{"key":"506_CR76","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1136\/bmj.324.7334.393","volume":"324","author":"B Taylor","year":"2002","unstructured":"Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ. 2002;324:393\u20136.","journal-title":"BMJ"},{"key":"506_CR77","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0140-6736(97)11096-0","volume":"351","author":"AJ Wakefield","year":"1998","unstructured":"Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351:637\u201341.","journal-title":"Lancet"},{"key":"506_CR78","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMoa021134","volume":"347","author":"KM Madsen","year":"2002","unstructured":"Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med. 2002;347:1477\u201382.","journal-title":"N Engl J Med"},{"key":"506_CR79","volume-title":"Epidemic modelling: an introduction Cambridge","author":"DJ Daley","year":"1999","unstructured":"Daley DJ, Gani J. Epidemic modelling: an introduction Cambridge. United Kingdom: Cambridge University Press; 1999."},{"key":"506_CR80","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1056\/NEJMp1408696","volume":"371","author":"W Orenstein","year":"2014","unstructured":"Orenstein W, Seib K. Mounting a good offense against measles. N Engl J Med. 2014;371:1661\u20133.","journal-title":"N Engl J Med"},{"key":"506_CR81","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/sj.clpt.6100407","volume":"82","author":"F DeStefano","year":"2007","unstructured":"DeStefano F. Vaccines and autism: evidence does not support a causal association. Clin Pharmacol Ther. 2007;82:756\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"506_CR82","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1017\/S031716710000528X","volume":"33","author":"A Doja","year":"2006","unstructured":"Doja A, Roberts W. Immunizations and autism: a review of the literature. Can J Neurol Sci. 2006;33:341\u20136.","journal-title":"Can J Neurol Sci"},{"key":"506_CR83","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1023\/A:1022123822135","volume":"29","author":"E Fombonne","year":"1999","unstructured":"Fombonne E. Are measles infections or measles immunizations linked to autism? J Autism Dev Disord. 1999;29:349\u201350.","journal-title":"J Autism Dev Disord"},{"key":"506_CR84","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/sj.mp.4001266","volume":"8","author":"E Fombonne","year":"2003","unstructured":"Fombonne E, Cook EH. MMR and autistic enterocolitis: consistent epidemiological failure to find an association. Mol Psychiatry. 2003;8:133\u20134.","journal-title":"Mol Psychiatry"},{"key":"506_CR85","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1056\/NEJMp0802904","volume":"358","author":"PA Offit","year":"2008","unstructured":"Offit PA. Vaccines and autism revisited\u2014the Hannah Poling case. N Engl J Med. 2008;358:2089\u201391.","journal-title":"N Engl J Med"},{"key":"506_CR86","doi-asserted-by":"publisher","first-page":"e836","DOI":"10.1542\/peds.2007-1760","volume":"121","author":"MJ Smith","year":"2008","unstructured":"Smith MJ, Ellenberg SS, Bell LM, Rubin DM. Media coverage of the measles-mumps-rubella vaccine and autism controversy and its relationship to MMR immunization rates in the United States. Pediatrics. 2008;121:e836\u201343.","journal-title":"Pediatrics"},{"key":"506_CR87","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1001\/jama.284.24.3145","volume":"284","author":"DR Feikin","year":"2000","unstructured":"Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA. 2000;284:3145\u201350.","journal-title":"JAMA"},{"key":"506_CR88","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.282.1.47","volume":"282","author":"DA Salmon","year":"1999","unstructured":"Salmon DA, Haber M, Gangarosa EJ, Phillips L, Smith NJ, Chen RT. Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. JAMA. 1999;282:47\u201353.","journal-title":"JAMA"},{"key":"506_CR89","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/aje\/kwn263","volume":"168","author":"SB Omer","year":"2008","unstructured":"Omer SB, Enger KS, Moulton LH, Halsey NA, Stokley S, Salmon DA. Geographic clustering of nonmedical exemptions to school immunization requirements and associations with geographic clustering of pertussis. Am J Epidemiol. 2008;168:1389\u201396.","journal-title":"Am J Epidemiol"},{"key":"506_CR90","first-page":"153","volume":"64","author":"J Zipprich","year":"2015","unstructured":"Zipprich J, Winter K, Hacker J, Xia D, Watt J, Harriman K. Measles outbreak\u2014California, December 2014-February 2015. MMWR Morb Mortal Wkly Rep. 2015;64:153\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Suppl 5","key":"506_CR91","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1469-0691.2012.03982.x","volume":"18","author":"P Carrillo-Santisteve","year":"2012","unstructured":"Carrillo-Santisteve P, Lopalco PL. Measles still spreads in Europe: who is responsible for the failure to vaccinate? Clin Microbiol Infect. 2012;18 Suppl 5:50\u20136.","journal-title":"Clin Microbiol Infect"},{"key":"506_CR92","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1016\/j.vaccine.2011.11.112","volume":"30","author":"A Kata","year":"2012","unstructured":"Kata A. Anti-vaccine activists, Web 2.0, and the postmodern paradigm\u2014an overview of tactics and tropes used online by the anti-vaccination movement. Vaccine. 2012;30:3778\u201389.","journal-title":"Vaccine"},{"key":"506_CR93","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/archpedi.159.5.470","volume":"159","author":"DA Salmon","year":"2005","unstructured":"Salmon DA, Moulton LH, Omer SB, DeHart MP, Stokley S, Halsey NA. Factors associated with refusal of childhood vaccines among parents of school-aged children: a case\u2013control study. Arch Pediatr Adolesc Med. 2005;159:470\u20136.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"506_CR94","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1001\/archpedi.159.10.929","volume":"159","author":"EA Flanagan-Klygis","year":"2005","unstructured":"Flanagan-Klygis EA, Sharp L, Frader JE. Dismissing the family who refuses vaccines: a study of pediatrician attitudes. Arch Pediatr Adolesc Med. 2005;159:929\u201334.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"506_CR95","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.amepre.2003.09.004","volume":"26","author":"GL Freed","year":"2004","unstructured":"Freed GL, Clark SJ, Hibbs BF, Santoli JM. Parental vaccine safety concerns. The experiences of pediatricians and family physicians. Am J Prev Med. 2004;26:11\u20134.","journal-title":"Am J Prev Med"},{"key":"506_CR96","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1542\/peds.2005-0316","volume":"115","author":"DS Diekema","year":"2005","unstructured":"Diekema DS. Responding to parental refusals of immunization of children. Pediatrics. 2005;115:1428\u201331.","journal-title":"Pediatrics"},{"key":"506_CR97","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4161\/hv.4.4.5752","volume":"4","author":"DA Salmon","year":"2008","unstructured":"Salmon DA, Pan WK, Omer SB, et al. Vaccine knowledge and practices of primary care providers of exempt vs. vaccinated children. Hum Vaccin. 2008;4:286\u201391.","journal-title":"Hum Vaccin"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-015-0506-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11908-015-0506-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-015-0506-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-015-0506-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:36:40Z","timestamp":1744173400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11908-015-0506-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,7]]},"references-count":97,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["506"],"URL":"https:\/\/doi.org\/10.1007\/s11908-015-0506-5","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,7]]},"assertion":[{"value":"7 October 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Compliance with Ethics Guidelines"}},{"value":"Nasia Safdar and Cybele Abad have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by the author.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"51"}}